Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Rotavirus
Findings from L.M.A. Goossens and co-researchers advance knowledge in rotavirus
April 16th, 2008
"The objective of this study was to estimate the cost-utility of mass vaccination of 0-4-year-old children with Rotarix (TM) in the Netherlands. We used a Markov process with Dutch data on incidence, resource use and costs (GP, hospitalisation, productivity loss and household costs) to compare vaccination to conventional treatment from a societal perspective," investigators in Netherlands report. "Utility toss due to rotavirus-induced diarrhoea was measured using EQ5D, with GPs and paediatricians serving as proxies to fill out the questions. As the costs of a vaccination course ranged from (sic)90 to (sic)100 per child, the cost-utility ratio varied from (sic)21,900 to...
Source: Vaccine Weekly (2008-04-16)
|
